Asia/Oceania
C2i Genomics, NuProbe Global Enter Strategic Alliance for AI-Based Cancer Detection, Monitoring
The deal, which expands C2i into China, will combine C2i's AI-based cancer platform with NuProbe's sequencing technology.
The firm said it has long-term plans to launch multiple miRNA screening tests for cancers that would run in labs or at the point of care using one blood sample.
Researchers in Thailand have developed a test using a sweat sample from the armpit to measure automatic compounds indicating SARS-CoV-2 infection.
Takara Bio Gets CE-IVD Mark for SARS-CoV-2 Test
The RT-qPCR-based test is designed to detect SARS-CoV-2 in nasopharyngeal or nasal swab samples, as well as crude saliva samples.
Mawi DNA Technologies Inks Japanese Distribution Deal With Fujifilm
The deal covers Mawi's line of iSWAB biosample collection products including one for SARS-CoV-2 molecular testing.
Sep 16, 2021
Hong Kong-Based Prenetics to go Public via SPAC
Aug 31, 2021